News Focus
News Focus
Replies to #64302 on Biotech Values
icon url

corpstrat

07/15/08 3:51 PM

#64303 RE: amylinterry #64302

So the SEC now thinks naked shorting is a bad thing if it hurts Wall Street? Who'd have thunk?

Well, biotech investors are not part of the club, the protected class - we knew that already. Who cares if a few thousand patients die younger of / suffer more from various diseases that would have been cured if a few biotechs had had the capital to complete their trials? Nobody who matters cares.

Although we've known all this, it is fun to see it confirmed, isn't it?
icon url

DewDiligence

07/16/08 10:29 AM

#64329 RE: amylinterry #64302

“For nearly as long as stock markets have existed, authorities have tried to restrict short selling. And for as long as they have tried, they have failed. In 1733, in the aftermath of the South Sea Bubble, the British House of Commons banned what today would be called naked short selling. The law remained in force for more than 150 years, even though, as financial historian Charles Duguid noted in 1901, ‘it was at no time seriously operative.’

On Apr. 10, 1792, the New York state legislature banned short selling. Five weeks later, two dozen stockbrokers banded together to sign the Buttonwood Agreement, which created what became the New York Stock Exchange, where short selling occurred with abandon.”


http://online.wsj.com/article/SB121614248005255151.html
icon url

DewDiligence

07/16/08 8:00 PM

#64347 RE: amylinterry #64302

Hmm… SEC announces a cosmetic change vis-à-vis short-selling and the Nasdaq composite soars 3%. Who knew it was this easy? :-)